Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 82 for “"Adaptive Designs"”.
-
Adaptive designs with covariates
Thesis (Ph. D.)--Michigan State University. Department of Statistics and Probability, 2004
-
Resampling methods for adaptive designs
Thesis (Ph. D.)--Michigan State University. Department of Statistics and Probability, 2005
-
Issues in Group Sequential/Adaptive Designs
… there has been great interest in the use of adaptive features in clinical trials (i.e., changes in design or analyses guided by examination of the accumulated data at an interim point in the trial) that may make the studies more efficient (e.g., shorter duration, fewer patients). Many …
-
Adaptive designs for complex dose finding studies
… toxicity or (and) efficacy characteristics. Designs for trials studying doses of a single cytotoxic drug are based on the fundamental assumption "the more the better", that is, the toxicity and efficacy increase with the dose. This monotonicity assumption can be violated for novel therapies …
-
Adaptive designs in phase II clinical trials
… necessary the development of more flexible and adaptive designs for the implementation of clinical trials. The objective of adaptive designs is to ensure direct and dynamic control of the effectiveness and the safety of a new treatment by allowing the adjustment of the elements of the study …
-
Covariates in adaptive designs for clinical trials
Thesis (Ph. D.)--Michigan State University. Department of Statistics and Probability, 1999
-
Response Adaptive Designs in the Presence of Mismeasurement
Response adaptive randomization represents a major advance in clinical trial methodology that helps balance the benefits of the collective and the benefits of the individual and improves efficiency without undermining the validity and integrity of the clinical research. Response adaptive designs …
-
Bayesian Adaptive Designs for Early Phase Clinical Trials
… the operating characteristics of the proposed designs through simulation studies and compare them to existing methods. The umbrella trial is a clinical trial strategy that accommodates the paradigm shift towards personalized medicine, which evaluates multiple investigational drugs in different …
-
Bayesian Adaptive Designs For Early Phase Clinical Trials
<p>My dissertation focuses mainly on Bayesian adaptive designs for phase I and phase II clinical trials. It includes three specific topics: <strong>(1)</strong> proposing a novel two-dimensional dose-finding algorithm for biological agents, <strong>(2)</strong> developing Bayesian adaptive …
-
Response adaptive designs for clinical trials with continuous outcomes
Response adaptive designs are developed for ethical considerations, which sequentially modify the treatment allocations based on the accumulating information in the trial so more patients receive the potentially better treatment. Yi and Wang (2009) proposed a variance-penalized criterion to …
-
Bayesian adaptive designs in phase I/II clinical trials
Recently, many Bayesian methods have been developed for dose-finding when simultaneously modeling both toxicity and efficacy outcomes in a blended phase I/II fashion. A further challenge arises when all the true efficacy data cannot be obtained quickly after the treatment, so that surrogate markers …
-
Adaptive designs for phase II clinical trials with binary endpoints.
… is variable and thus not desirable. Also, adaptive designs do not follow the tradition of evaluating an entire sample of patients before analyzing the data. For an adaptive design with early stopping for either futility or efficacy, experimental designs are provided for some of the more …
-
Bayesian adaptive designs for non-inferiority and dose selection trials.
… admit ease of interpretation. Bayesian adaptive sampling methods offer the potential to accelerate the investigation of a drug without compromising the safety of the trial's participants. These methods select a patient's treatment based upon prior information and the knowledge accrued …
-
Innovative adaptive designs in oncology clinical trials with drug combinations
… In early phase trials, we propose a Bayesian adaptive phase I trial design that allows the investigator to attribute a DLT to one or both agents in a unknown fraction of patients, even when the drugs are given concurrently. We also propose a Bayesian adaptive phase I/II design with drug …
-
Novel Bayesian Adaptive Designs for Early Phase Oncology Clinical Trials
Bayesian adaptive clinical trial designs are slowly gaining momentum in practice due to their accuracy, flexibility and efficiency in evaluating a novel drug. In this thesis, we propose novel Bayesian adaptive designs for early phase oncology trials. First, we discuss a Phase I-II trial design for …
-
The Utility of Adaptive Designs in Publicly Funded Confirmatory Trials
Introduction: Adaptive designs (ADs) are underused, particularly in publicly funded confirmatory trials, despite their promising benefits and methodological prominence given in the statistical literature. Research Question: This thesis investigates why ADs are underused in the publicly funded …
-
Multiple testing problems in classical clinical trial and adaptive designs
… the increasing number of complex clinical trial designs. In general, two types of multiple testing can be performed (Dmitrienko et al., 2009): union-intersection testing (UIT) and intersection-union testing (IUT). The UIT is of the interest in this dissertation. Thus, the familywise error rate …
-
Bayesian Adaptive Designs For Proof-of-Concept Trials and Platform Trials
… It’s crucial to develop novel phase II trial designs to accomplish different objectives for different types of trials. This research mainly focuses on Bayesian adaptive designs for phase II trials. Three types of trials are discussed in which traditional designs may encounter limitations, and …
Page 1 of 5